As part of our ongoing series here at The Acquirer’s Multiple, we provide this feature article titled ‘Stock in Focus‘ where we focus on one of the stocks from our Stock Screeners.
One of the cheapest stocks in our Stock Screeners is:
Quidel Corporation (NASDAQ: QDEL)
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.
A quick look at the share price history for the company (below) over the past twelve months shows that the price is down 57%. Here’s why the company remains undervalued.
Market Cap: $3.69 Billion
Enterprise Value: $3.25 Billion
Operating Earnings: $1.15 Billion
Acquirer’s Multiple: 2.83
Free Cash Flow (TTM)
Free Cash Flow: $634 Million
FCF/EV Yield: 20%
Piotroski F-Score: 9
Altman Z-Score: 8.97
Beneish M-Score: -2.23
Shareholder Yield: 3%
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple: